Western blot shows lysates of J774A.1 mouse reticulum cell sarcoma macrophage cell line and NR8383 rat alveolar macrophage cell line. PVDF membrane was probed with 0.5 µg/mL of Goat Anti-Human/Mouse/Rat MIF ...read more
Western blot shows lysates of THP‑1 human acute monocytic leukemia cell line and U937 human histiocytic lymphoma cell line. PVDF membrane was probed with 0.5 µg/mL of Goat Anti-Human/Mouse/Rat MIF Antigen ...read more
MIF (or macrophage migration inhibitory factor) was the first lymphokine/cytokine to be recognized in the pregenomics era (1, 2). Regardless, it is one of the least understood of all inflammatory mediators (1, 3). Human MIF is a 12.5 kDa, 115 amino acid (aa) nonglycosylated polypeptide that is synthesized without a signal sequence (4-7). Secretion occurs non-classically via an ABCA1 transporter (8). The initiating Met is removed, leaving Pro as the first amino acid. The molecule consists of two alpha -helices and six beta -strands, four of which form a beta -sheet. The two remaining beta -strands interact with other MIF molecules, creating a trimer (2, 9, 10). Structure-function studies suggest MIF is bifunctional with segregated topology. The N- and C-termini mediate enzyme activity (in theory). Phenylpyruvate tautomerase activity (enol-to-keto) has been demonstrated and is dependent upon Pro at position #1 (11). Amino acids 50-65 have also been suggested to contain thiol-protein oxidoreductase activity (12). MIF has proinflammatory cytokine activity centered around aa’s 49-65. On fibroblasts, MIF induces, IL-1, IL-8, and MMP expression; on macrophages, MIF stimulates NO production and TNF-alpha release following IFN-gamma activation (13, 14). MIF apparently acts through CD74 and CD44, likely in some form of trimeric interaction (15, 16). Human MIF is active on mouse cells (14). Human MIF is 90%, 94%, 95%, and 90% aa identical to mouse, bovine, porcine, and rat MIF, respectively.
Norand, E.F. and M. Leech (2005) Front. Biosci. 10:12.
Donn, R.P. and D.W. Ray (2004) J. Endocrinol. 182:1.
Calandra, T. and T. Roger (2003) Nat. Rev. Immunol. 3:791.
Kozak, C.A. et al. (1995) Genomics 27:405.
Weiser, W.Y. et al. (1989) Proc. Natl. Acad. Sci. USA 86:7522.
Paralkar, V. and G. Wistow (1994) Genomics 19:48.
Wistow, G.J. et al. (1993) Proc. Natl. Acad. Sci. USA 90:1272.
Flieger, O. et al. (2003) FEBS Lett. 551:78.
Philo, J.S. et al. (2004) Biophys. Chem. 108:77.
Sun, H-W. et al. (1996) Protein Eng. 9:631.
Stamps, S.L. et. al. (2000) Biochemistry 39:9671.
Nguyen, M.T. et al. (2003) J. Biol. Chem. 278:33654.
Sato, A. et al. (2003) Dev. Comp. Immunol. 27:401.
Bernhagen, J. et al. (1994) Biochemistry 33:14144.
Leng, L. et al. (2003) J. Exp. Med. 197:1467.
Meyer-Siegler, K.L. and P.L. Vera (2005) J. Urol. 173:615.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our MIF Antibody [Unconjugated] and receive a gift card or discount.